Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus: Aquitaine cohort, France, 1986-1997

Cancer

Volumn 88, Issue 7, 2000, Pages 1696-1702

  Thiessard, Frantz ^a   Morlat, Philippe ^b   Marimoutou, Catherine ^a   Labouyrie, Eric ^c   Ragnaud, Jean Marie ^d   Pellegrin, Jean Luc ^c   Dupon, Michel ^d   Dabis, François ^a,e  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

^c HAUT LÉVÊQUE HOSPITAL   (France)

^d HÔPITAL PELLEGRIN   (France)

^e INSERM   (France)

Author keywords

Acquired immunodeficiency syndrome; HAART; Human immunodeficiency virus; Lymphoma; Non Hodgkin; Survival analysis

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; HEMOGLOBIN; METHOTREXATE; PREDNISONE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VINCRISTINE; VINDESINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; ANTINEOPLASTIC AGENTS; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; PROTEASE INHIBITORS; REVERSE TRANSCRIPTASE INHIBITORS; TIME FACTORS;

EID: 0034177499     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000401)88:7<1696::AID-CNCR25>3.0.CO;2-L     Document Type: Article

References (33)

1. Sparano JA, Hu X, Wiernik PH, Sarta C, Reddy DM, Hanau L, et al. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy. J Natl Cancer Inst 1997;89:301-7.
2. Levine AM. Lymphoma complicating immunodeficiency disorders. Ann Oncol 1994;5:29-35.
3. CDC. Revision of the case definition of acquired immunodeficiency syndrome for national reporting. MMWR Mo/b Mortal Wkly Rep 1985;34:373-5.
4. Cote TR, Biggar RJ, Rosenberg PS, Devesa SS, Percy C, Yellin FJ, et al. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer 1997;73:645-50.
5. Pedersen C, Barton SE, Chiesi A, Skinhoj P, Katlama C, Johnson A, et al. HIV-related non-Hodgkin's lymphoma among European AIDS patients. AIDS in Europe Study Group. AIDS in Europe Study Group. Eur J Haematol 1995; 55:245-50.
6. Lundgren JD, Pedersen C, Clumeck N, Gatell JM, Johnson AM, Ledergerber B, et al. Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group. BMJ 1994;308:1068-73.
7. Beral V, Peterman HJ, Berkelman R. AIDS-associated non-Hodgkin lymphoma. Lancet 1991;337:805-9.
8. Serraino D, Salamina G, Franceschi S, Dubois D, La Vecchia C, Brunet JB, et al. The epidemiology of AIDS-associated non-Hodgkin's lymphoma in the World Health Organization European Region. Br J Cancer 1992;66:912-6.
9. Tirelli U, Errante D, Carbone A, Gloghini A, Vaccher E. Malignant lymphomas in patients with HIV infection. Leuk Lymphoma 1996;22:245-57.
10. Mocroft AJ, Lundgren JD, d'Armino Monforte A, Ledergerber B, Barton SE, Vella S, et al. Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. Int J Epidemiol 1997;26:400-7.
11. Lifermann F, Lacoste D, Merlio JP, Chene G, Beylot J. Lymphomes malins non Hodgkiniens et virus de l'immunodéficience humaine. A propos de 34 observations. Ann Med Interne (Paris) 1992;143:309-14.
12. Roithmann S, Toledano M, Tourani JM, Raphael M, Gentilini M, Gastaut JA, et al. HIV-associated non-Hodgkin's lymphomas: clinical characteristics and outcome. The experience of the French Registry of HIV-associated tumors. Ann Oncol 1991;2:289-95.
13. Levine AM, Sullivan-Halley J, Pike MC, Rarick MU, Loureiro C, Bernstein-Singer M, et al. Human immunodeficiency virus-related lymphoma-prognostic factors predictive of survival. Cancer 1991;68:2466-72.
14. Tirelli U, Spina M, Vaccher E, Errante D, Tavio M, Simonelli C, et al. Clinical evaluation of 451 patients with HIV related non-Hodgkin's lymphoma: experience on the Italian cooperative group on AIDS and tumors (GICAT). Leuk Lymphoma 1995;20:91-6.
15. Kaplan LD, Abrams DI, Feigal E, McGrath M, Kahn J, Neville P, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989;261:719-24.
16. Kaplan LD, Shiramizu B, Herndier B, Hahn J, Meeker TC, Ng V, et al. Influence of molecular characteristics of clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome. Blood 1995;85:1727-35.
17. Straus DJ, Huang J, Testa MA, Levine AM, Kaplan LD. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142-low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases. J Clin Oncol 1998;16:3601-6.
18. Tirelli U, Errante D, Spina M, Vaccher E, Serraino D, Boiocchi M, et al. Long-term survival of patients with HIV-related systemic non-Hodgkin's lymphomas. Hematol Oncol 1996; 14:7-15.
19. Spira R, Marimoutou C, Binquet C, Lacoste D, Dabis F. Rapid change in the use of antiretroviral agents and improvement in a population of HIV-infected patients: France, 1995-1997. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA). J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:358-64.
20. Tirelli U, Franceschi S, Carbone A. Malignant tumours in patients with HIV infection. BMJ 1994;308:1148-53.
21. Marimoutou C, Chene G, Dabis F, Lacoste D, Salamon R. Human immunodeficiency virus infection and AIDS in Aquitaine. 10 years' experience of a hospital information system, 1985-1995. Le Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA). Presse Med 1997;26:703-10.
22. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971;31:1860-1.
23. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982;49:2112-35.
24. Curiel TJ, Piche A, Kasono K, Curiel DT. Gene therapy strategies for AIDS-related malignancies. Gene Ther 1997;4:1284-8.
25. Saah AJ, Hoover DR, He Y, Kingsley LA, Phair JP. Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS). J Acquir Immune Defic Syndr 1994;7:287-95.
26. Volm MD, Von Roenn JH. AIDS-associated lymphoma. In: Tallman NS, Gordon LI, editors. Diagnosis and therapeutic advances in hematologic malignancies. Boston: Kluwer Academic Publishers, 1999:241-66.
27. Apolonio EG, Hoover DR, He Y, Saah AJ, Lyter DW, Detels R, et al. Prognostic factors in human immunodeficiency virus-positive patients with a CD4+ lymphocyte count < 50/ microL. J Infect Dis 1995;171:829-36.
28. Pittaluga S, Bijnens L, Teodorovic I, Hagenbeek A, Meerwaldt JH, Somers R, et al. Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation. Blood 1996;87:4358-67.
29. Navarro JT, Ribera JM, Oriol A, Vaquero M, Romeu J, Batlle M, et al. International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's lymphoma treated with CHOP. A multivariate study of 46 patients. Haematologica 1998;83:508-13.
30. Stansfeld AG, Diebold J, Noel H, Kapanci Y, Rilke F, Kelenyi G, et al. Updated Kiel classification for lymphomas. Lancet 1988;1:292-93.
31. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
32. Herrinton LJ. Epidemiology of the Revised European-American Lymphoma Classification subtypes. Epidemiol Rev 1998;20:187-203.
33. Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP, et al. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 1997;336:1641-8.